A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

The purpose of this study is to investigate the pharmacokinetics and safety of OPA-15406 in adult subjects with atopic dermatitis

Phase 1

Otsuka Pharmaceutical Development & Commercialization, Inc.

Tacrolimus